Autobio Diagnostics Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2019
October 28, 2019 at 06:29 am EDT
Share
Autobio Diagnostics Co., Ltd. announced earnings results for the nine months ended September 30, 2019. For the nine months, the company announced sales was CNY 1,893.626 million compared to CNY 1,360.205 million a year ago. Operating income was CNY 629.586 million compared to CNY 473.990 million a year ago. Net income was CNY 537.907 million compared to CNY 411.013 million a year ago. Basic earnings per share from continuing operations was CNY 1.28 compared to CNY 0.98 a year ago.
Autobio Diagnostics Co., Ltd. is a China-based company and mainly engaged in development, manufacture and sales of diagnostics products. The Company's main products include gnostic products, microbiology detection products, and related devices. The immunodiagnostic products include microplate chemiluminescence diagnostic reagents, Enzyme-Linked immunosorbent assay diagnostic reagents, magnetic particle chemiluminescence detection reagents, and colloidal diagnostic reagents. The microbiology detection products include training detection reagents, susceptibility detection reagents and rapid detection reagents. The device products include microplate readers, chemiluminescence immunoassay analyzers, and united testing analyzers. The Company distributes its products in domestic markets.
AUTOBIO DIAGNOSTICS CO., LTD. 
